Abstract:Recently, 'tangible' virtual libraries have made billions of molecules readily available. Prioritizing these molecules for synthesis and testing demands computational approaches, such as docking. We will present recent results in which protein structure is interrogated using molecular docking, resulting in new high-affinity compounds that exhibit new biology in animal models. Singh I, Seth A, Billesbølle CB, Braz J, Rodriguiz RM, Roy K, Bekele B, Craik V, Huang XP, Boytsov D, Pogorelov VM, Lak P, O'Donnell H, Sandtner W, Irwin JJ, Roth BL, Basbaum AI, Wetsel WC, Manglik A, Shoichet BK, Rudnick G. Structure-based discovery of conformationally selective inhibitors of the serotonin transporter. Cell. 2023 May 11;186(10):2160-2175.e17. doi: 10.1016/j.cell.2023.04.010. Epub 2023 May 2. PMID: 37137306; PMCID: PMC10306110. Fink EA, Xu J, Hübner H, Braz JM, Seemann P, Avet C, Craik V, Weikert D, Schmidt MF, Webb CM, Tolmachova NA, Moroz YS, Huang XP, Kalyanaraman C, Gahbauer S, Chen G, Liu Z, Jacobson MP, Irwin JJ, Bouvier M, Du Y, Shoichet BK, Basbaum AI, Gmeiner P. Structure-based discovery of nonopioid analgesics acting through the α2A-adrenergic receptor. Science. 2022 Sep 30;377(6614):eabn7065. doi: 10.1126/science.abn7065. Epub 2022 Sep 30. PMID: 36173843; PMCID: PMC10360211. Kaplan AL, Confair DN, Kim K, Barros-Álvarez X, Rodriguiz RM, Yang Y, Kweon OS, Che T, McCorvy JD, Kamber DN, Phelan JP, Martins LC, Pogorelov VM, DiBerto JF, Slocum ST, Huang XP, Kumar JM, Robertson MJ, Panova O, Seven AB, Wetsel AQ, Wetsel WC, Irwin JJ, Skiniotis G, Shoichet BK, Roth BL, Ellman JA. Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity. Nature. 2022 Oct;610(7932):582-591. doi: 10.1038/s41586-022-05258-z. Epub 2022 Sep 28. PMID: 36171289; PMCID: PMC9996387. Citation Format: J. Irwin. Virtual screening of ultra-large chemical spaces for novel chemotype discovery [abstract]. In: Proceedings of the 2023 San Antonio Breast Cancer Symposium; 2023 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2024;84(9 Suppl) nr Wrk2-04.

Revisiting Pyrimidine-Embedded Molecular Frameworks to Probe the Unexplored Chemical Space for Protein-Protein Interactions

Small molecules, big targets: drug discovery faces the protein–protein interaction challenge

Computational Modeling as a Tool to Investigate PPI: From Drug Design to Tissue Engineering

Evolution of In Silico Strategies for Protein-Protein Interaction Drug Discovery

Computational Approaches for the Design of Modulators Targeting Protein-Protein Interactions

Main methods and tools for peptide development based on protein-protein interactions (PPIs)

Chemical-Protein Interactome and Its Application in Off-Target Identification

Hotspot Identification and Drug Design of Protein-Protein Interaction Modulators Using the Fragment Molecular Orbital Method

Rational design of small-molecule peptidomimetics for three pivotal protein secondary structures

Exploring the chemical space of protein–protein interaction inhibitors through machine learning

Benchmark Study Based on 2P2I(DB) to Gain Insights into the Discovery of Small-Molecule PPI Inhibitors

Rational Design of Peptide-Based Inhibitors Disrupting Protein-Protein Interactions

A Comprehensive Review on Current Advances in Peptide Drug Development and Design

Computational Methods-Guided Design of Modulators Targeting Protein-Protein Interactions (Ppis)

Polymers for Disrupting Protein-Protein Interactions: Where Are We and Where Should We Be?

Interface-aware molecular generative framework for protein-protein interaction modulators

Abstract Wrk2-04: Virtual screening of ultra-large chemical spaces for novel chemotype discovery

Small molecules targeting protein‒protein interactions for cancer therapy

Targeting Protein-Protein Interaction by Small Molecules

Chemical and Biological Strategies for Profiling Protein-Protein Interactions in Living Cells.

De novo molecular design with deep molecular generative models for PPI inhibitors